Meds & supplements › Tranexamic acid
Medicine · Antifibrinolytic Agent
Tranexamic acid tablets are indicated for the treatment of cyclic heavy menstrual bleeding in females of reproductive potential.
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Tranexamic acid injection is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
The following clinically significant adverse reactions are described elsewhere in the labeling:
Tranexamic acid Injection is contraindicated:
sofidex [Internet]. Daloreum; c2026. Tranexamic acid; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/tranexamic-acid
sofidex. (2026, August 3). Tranexamic acid. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/tranexamic-acid
Tranexamic acid. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/tranexamic-acid
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.